Cui Y, Blumenthal R S, Flaws J A, Whiteman M K, Langenberg P, Bachorik P S, Bush T L
Director, Ciccarone Heart Center, The Johns Hopkins University, 600 W Wolfe St, Carnegie 538, Baltimore, MD 21287, USA.
Arch Intern Med. 2001 Jun 11;161(11):1413-9. doi: 10.1001/archinte.161.11.1413.
Non-high-density lipoprotein cholesterol (non-HDL-C) contains all known and potential atherogenic lipid particles. Therefore, non-HDL-C level may be as good a potential predictor of risk for cardiovascular disease (CVD) as low-density lipoprotein cholesterol (LDL-C).
To determine whether non-HDL-C level could be useful in predicting CVD mortality and to compare the predictive value of non-HDL-C and LDL-C levels.
Data are from the Lipid Research Clinics Program Follow-up Study, a mortality study with baseline data gathered from 1972 through 1976, and mortality ascertained through 1995. A total of 2406 men and 2056 women aged 40 to 64 years at entry were observed for an average of 19 years, with CVD death as the main outcome measure.
A total of 234 CVD deaths in men and 113 CVD deaths in women occurred during follow-up. Levels of HDL-C and non-HDL-C at baseline were significant and strong predictors of CVD death in both sexes. In contrast, LDL-C level was a somewhat weaker predictor of CVD death in both. Differences of 0.78 mmol/L (30 mg/dL) in non-HDL-C and LDL-C levels corresponded to increases in CVD risk of 19% and 15%, respectively, in men. In women, differences of 0.78 mmol/L (30 mg/dL) in non-HDL-C and LDL-C levels corresponded to increases in CVD risk of 11% and 8%, respectively.
Non-HDL-C level is a somewhat better predictor of CVD mortality than LDL-C level. Screening for non-HDL-C level may be useful for CVD risk assessment.
非高密度脂蛋白胆固醇(non-HDL-C)包含所有已知的和潜在的致动脉粥样硬化脂质颗粒。因此,非高密度脂蛋白胆固醇水平可能与低密度脂蛋白胆固醇(LDL-C)一样,是心血管疾病(CVD)风险的良好潜在预测指标。
确定非高密度脂蛋白胆固醇水平是否有助于预测心血管疾病死亡率,并比较非高密度脂蛋白胆固醇和低密度脂蛋白胆固醇水平的预测价值。
数据来自脂质研究临床项目随访研究,这是一项死亡率研究,其基线数据收集于1972年至1976年,死亡率确定至1995年。共有2406名年龄在40至64岁之间的男性和2056名女性入组,平均观察19年,以心血管疾病死亡作为主要结局指标。
随访期间,男性共发生234例心血管疾病死亡,女性共发生113例心血管疾病死亡。基线时的高密度脂蛋白胆固醇和非高密度脂蛋白胆固醇水平是两性心血管疾病死亡的显著且强有力的预测指标。相比之下,低密度脂蛋白胆固醇水平在两性中对心血管疾病死亡的预测作用稍弱。男性中非高密度脂蛋白胆固醇和低密度脂蛋白胆固醇水平相差0.78 mmol/L(30 mg/dL)分别对应心血管疾病风险增加19%和15%。女性中非高密度脂蛋白胆固醇和低密度脂蛋白胆固醇水平相差0.78 mmol/L(30 mg/dL)分别对应心血管疾病风险增加11%和8%。
非高密度脂蛋白胆固醇水平对心血管疾病死亡率的预测作用略优于低密度脂蛋白胆固醇水平。筛查非高密度脂蛋白胆固醇水平可能有助于心血管疾病风险评估。